ALTSGEYMER KASALLIGI VA UNI AN’ANAVIY DAVOLASH USULLARI HAMDA TATQIQOT JARAYONIDAGI YANGI DAVOLASH USULLARI
Kalit so‘zlar:
Altsgeymer kasalligi, demensiya, xolinesteraza ingibitori, memantin, donepezil, NMDA-retseptori, zamonaviy davolash tadqiqotlari, NAD⁺, P7C3-A20Abstrak
Ushbu maqolada Altsgeymer kasalligi haqida umumiy va zamonaviy ilmiy qarashlar yoritilgan. Xususan, kasallikning tarixi, kelib chiqish sabablari va patogenez mexanizmlari tahlil qilingan. Shuningdek, Altsgeymer kasalligini davolashda hozirda qo‘llanilayotgan asosiy dori vositalari, jumladan xolinesteraza ingibitorlari va NMDA-retseptor antagonistlarining ta’sir mexanizmlari ko‘rib chiqilgan. Bundan tashqari, maqolada kasallikni sekinlashtirishga qaratilgan an’anaviy davolash usullari bilan bir qatorda, Altsgeymer kasalligini davolashga qaratilgan yangi ilmiy tadqiqotlar, xususan miya hujayralarining energiya muvozanati va NAD⁺ molekulasi bilan bog‘liq zamonaviy yondashuvlar muhokama qilingan. Ushbu tadqiqotlar kelajakda kasallikni nafaqat sekinlashtirish, balki uning rivojlanishini qaytarish imkoniyatlarini ochib berishi mumkin. Maqola Altsgeymer kasalligini chuqurroq tushunish va uni davolashning istiqbolli yo‘nalishlarini yoritishga qaratilgan..
References
Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie. 1907;64:146–148.
Khann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R. et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the NIA-AA workgroups. Alzheimer’s & Dementia. 2011;7(3):263–269.
Selkoe D.J., Hardy J. The amyloid hypothesis of Alzheimer’s disease: Progress and problems. EMBO Molecular Medicine. 2016;8(6):595–608.
Cummings J., Lee G., Zhong K., Fonseca J., Taghva K. Alzheimer’s disease drug development pipeline: 2023. Alzheimer’s & Dementia. 2023;19(6):2243–2255.
Parsons C.G., Stöffler A., Danysz W. Memantine: A NMDA receptor antagonist for the treatment of Alzheimer’s disease. Neuropharmacology. 2007;53(6):699–723.
Rogers S.L., Doody R.S., Mohs R.C., Friedhoff L.T. Donepezil improves cognition and global function in Alzheimer’s disease. Neurology. 1998;50(1):136–145.
Longo V.D., Mattson M.P. Fasting, energy metabolism, and Alzheimer’s disease. Cell Metabolism. 2014;20(4):523–534.
Katsyuba E., Auwerx J. Modulating NAD⁺ metabolism, from bench to bedside. Cell Metabolism. 2017;26(3):529–547.
Pieper A.A., Xie S., Capota E. et al. Discovery of a proneurogenic, neuroprotective chemical. Cell. 2010;142(1):39–51.
Ibodullayev Z.R. Umumiy nevrologiya. Toshkent: Zamin Nashr; 2021.
(+998)90 142-39-38
Andijon viloyati, Marhamat tumani, Qashqar ko’chasi 189-uy